Blood Pressure Goals and Treatment in Pregnant Patients With Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 22, Issue 2, 2015, Pages 165-169

  Hussain, Asher ^a,b,c   Karovitch, Alan ^a,b,c   Carson, Michael P ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Department of Surgery   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

CKD; End stage kidney disease; Hypertension; Pre eclampsia; Pregnancy

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; LABETALOL; LOOP DIURETIC AGENT; NIFEDIPINE; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CESAREAN SECTION; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; REVIEW; ADULT; AGE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; COMORBIDITY; DIABETES MELLITUS; DISEASE MANAGEMENT; DRUG EFFECTS; FEMALE; HYPERTENSION; OBESITY; ORGANIZATION AND MANAGEMENT; PERINATAL CARE; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; PREVALENCE; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY;

ADULT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; COMORBIDITY; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; OBESITY; PERINATAL CARE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84923847897     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.08.002     Document Type: Review

References (37)

1. Mathews T.J., Hamilton B.E. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief. No. 21 2009, U.S. Department of Health and Human Services, Hyattsville, MD. Statistics NCfH (Ed.).
2. CDC.gov. Overweight and obesity. 2012. Available at: Accessed July 24,2012. http://www.cdc.gov/obesity/data/trends.html.
3. Williams D., Davison J. Chronic kidney disease in pregnancy. BMJ 2008, 336(7637):211-215.
4. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 suppl 1):S1-S266. National Kidney F.
5. Hussein W., Lafayette R.A. Renal function in normal and disordered pregnancy. Curr Opin Nephrol Hypertens 2014, 23(1):46-53.
6. Carson M.P., Pagan E.R. Effects of pregnancy on common laboratory tests. de Swiet's Medical Disorders in Obstetric Practice 2010, 661-670. Wiley-Blackwell, Hoboken, NJ. 5th ed. R.O. Powrie, M.F. Greene, W. Camann (Eds.).
7. Vellanki K., Hou S. The kidney in pregnancy. National Kidney Foundation Primer on Kidney Diseases 2014, 427-436. Elsevier Saunders, Philadelphia, PA. 6th ed. S. Gilbert, D. Weiner (Eds.).
8. Hayslett J.P. Interaction of renal disease and pregnancy. Kidney Int 1984, 25(3):579-587.
9. Bili E., Tsolakidis D., Stangou S., Tarlatzis B. Pregnancy management and outcome in women with chronic kidney disease. Hippokratia 2013, 17(2):163-168.
10. Jones D.C., Hayslett J.P. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996, 335(4):226-232.
11. Jungers P., Houillier P., Forget D., Henry-Amar M. Specific controversies concerning the natural history of renal disease in pregnancy. Am J Kidney Dis 1991, 17(2):116-122.
12. Fischer M.J., Lehnerz S.D., Hebert J.R., Parikh C.R. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis 2004, 43(3):415-423.
13. Nevis I.F., Reitsma A., Dominic A., et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol 2011, 6(11):2587-2598.
14. Jungers P., Chauveau D. Pregnancy in renal disease. Kidney Int 1997, 52(4):871-885.
15. Palma-Reis I., Vais A., Nelson-Piercy C., Banerjee A. Renal disease and hypertension in pregnancy. Clin Med 2013, 13(1):57-62.
16. Hypertension in pregnancy. Obstet Gynecol 2013, 122(5):1122-1131. Task Force on Hypertension in Pregnancy.
17. von Dadelszen P., Magee L.A. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 2002, 24(12):941-945.
18. Hladunewich M.A., Hou S., Odutayo A., et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States Cohort Comparison. J Am Soc Nephrol 2014, 25(5):1103-1109.
19. Hou S. Pregnancy in women on dialysis: is success a matter of time?. Clin J Am Soc Nephrol 2008, 3(2):312-313.
20. Barua M., Hladunewich M., Keunen J., et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol 2008, 3(2):392-396.
21. Liu J., Zhao Y., Song Y., et al. Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women. J Matern Fetal Neonatal Med 2012, 25(3):261-266.
22. Kuller J.A., D'Andrea N.M., McMahon M.J. Renal biopsy and pregnancy. Am J Obstet Gynecol 2001, 184(6):1093-1096.
23. Piccoli G.B., Daidola G., Attini R., et al. Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. BJOG 2013, 120(4):412-427.
24. Packham D., Fairley K.F. Renal biopsy: indications and complications in pregnancy. Br J Obstet Gynaecol 1987, 94(10):935-939.
25. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011, 32(24):3147-3197. European Society of Gynecology, Association for European Paediatric CardiologyAssociation for European Paediatric Cardiology, German Society for Gender MedicineGerman Society for Gender Medicine, etaletal.
26. Maloni J.A. Lack of evidence for prescription of antepartum bed rest. Expert Rev Obstet Gynecol 2011, 6(4):385-393.
27. Cockburn J., Moar V.A., Ounsted M., Redman C.W. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982, 1(8273):647-649.
28. Molvi S.N., Mir S., Rana V.S., Jabeen F., Malik A.R. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa. Arch Gynecol Obstet 2012, 285(6):1553-1562.
29. Lydakis C., Lip G.Y., Beevers M., Beevers D.G. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999, 12(6):541-547.
30. Smith P., Anthony J., Johanson R. Nifedipine in pregnancy. BJOG 2000, 107(3):299-307.
31. ACOG practice bulletin Number 33. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002, 99(1):159-167. American College of Obstetricians and Gynecologists.
32. Gillman M.W., Ross-Degnan D., McLaughlin T.J., et al. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction. J Am Geriatr Soc 1999, 47(5):512-517.
33. Gansevoort R.T., de Zeeuw D., de Jong P.E. ACE inhibitors and proteinuria. Pharm World Sci 1996, 18(6):204-210.
34. Galle J. Reduction of proteinuria with angiotensin receptor blockers. Nat Clin Pract Cardiovasc Med 2008, 5(suppl 1):S36-S43.
35. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006, 354(23):2443-2451.
36. Li D.K., Yang C., Andrade S., Tavares V., Ferber J.R. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 2011, 343:d5931.
37. Lewis G., Maxwell A.P. Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?. Diabetologia 2014, 57(5):1082-1083.